Literature DB >> 8425450

Regression of Barrett's esophagus by laser ablation in an anacid environment.

R E Sampliner1, L J Hixson, M B Fennerty, H S Garewal.   

Abstract

Consistent regression of intestinal metaplasia in Barrett's esophagus has not been achieved with medical or surgical interventions. In this case report, a patient with Barrett's esophagus of stable length had half the circumference of the Barrett's epithelium ablated with laser therapy while on a high-dose proton-pump inhibitor. In the absence of esophageal acid exposure and after laser ablation, the intestinal metaplasia was documented to reepithelialize with normal squamous mucosa, which has persisted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425450     DOI: 10.1007/bf01307557

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury?

Authors:  S Sartori; I Nielsen; M Indelli; L Trevisani; P Pazzi; E Grandi
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

2.  Regression of Barrett's epithelium with omeprazole.

Authors:  J Deviere; M Buset; J M Dumonceau; F Rickaert; M Cremer
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

3.  Treatment of Barrett's esophagus with H2 blockers.

Authors:  B T Cooper; G O Barbezat
Journal:  J Clin Gastroenterol       Date:  1987-04       Impact factor: 3.062

Review 4.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

5.  Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus.

Authors:  I C Wesdorp; J Bartelsman; M E Schipper; G N Tytgat
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

6.  Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery.

Authors:  D L Brand; J T Ylvisaker; M Gelfand; C E Pope
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

7.  Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

Authors:  M J Collen; J H Lewis; S B Benjamin
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

8.  Barrett's esophagus: clinical, endoscopic, and histologic spectrum in fifty patients.

Authors:  P Kerlin; G d'Mellow; A van Deth
Journal:  Aust N Z J Med       Date:  1986-04

9.  Effect of antireflux operation on Barrett's mucosa.

Authors:  W A Williamson; F H Ellis; S P Gibb; D M Shahian; H T Aretz
Journal:  Ann Thorac Surg       Date:  1990-04       Impact factor: 4.330

10.  Lack of impact of therapy on extent of Barrett's esophagus in 67 patients.

Authors:  R E Sampliner; H S Garewal; M B Fennerty; M Aickin
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

View more
  18 in total

1.  Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?

Authors:  R Ackroyd; N J Brown; T J Stephenson; C J Stoddard; M W Reed
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

Review 3.  Endoscopic ablation of Barrett's esophagus.

Authors:  M B Fennerty
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 4.  Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.

Authors:  Drew B Schembre
Journal:  J Gastrointest Surg       Date:  2009-03-26       Impact factor: 3.452

Review 5.  Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem.

Authors:  M S Levine; J B Herman; E E Furth
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

6.  Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus.

Authors:  R Fass; J M Yalam; L Camargo; C Johnson; H S Garewal; R E Sampliner
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

7.  How I Treat Patients With Barrett Esophagus When Endoscopic Ablation Fails.

Authors:  Kenneth K Wang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-02

8.  Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation.

Authors:  C P Barham; R L Jones; L R Biddlestone; R H Hardwick; N A Shepherd; H Barr
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

9.  Resection and advancement of esophageal mucosa. A potential therapy for Barrett's esophagus.

Authors:  T M Farrell; S B Archer; R E Metreveli; C D Smith; J G Hunter
Journal:  Surg Endosc       Date:  2001-07-05       Impact factor: 4.584

10.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.

Authors:  J Regula; A J MacRobert; A Gorchein; G A Buonaccorsi; S M Thorpe; G M Spencer; A R Hatfield; S G Bown
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.